Action CODX CO-DIAGNOSTICS, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Co-Diagnostics, Inc.

Actions

CODX

US1897631057

Temps réel estimé Cboe BZX
Autres places de cotation
 16:03:10 14/05/2024 		Varia. 5j. Varia. 1 janv.
1,095 USD +1,86 % Graphique intraday de Co-Diagnostics, Inc. -13,49 % -18,05 %
13/05 CO-DIAGNOSTICS, INC. : HC Wainwright toujours neutre sur le dossier ZM
09/05 Transcript : Co-Diagnostics, Inc., Q1 2024 Earnings Call, May 09, 2024

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Co-Diagnostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results
Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast
Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in Taiwan
Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event
Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event
Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event
Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions
Co-Diagnostics, Inc. Appoints Executive Appointments
Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote Address
Co-Diagnostics, Inc. CEO to Deliver Keynote Address at MarketsandMarkets 2024 in London, England
Co-Diagnostics, Inc. Appoints Richard Abbott as President
Tranche Update on Co-Diagnostics, Inc.'s Equity Buyback Plan announced on March 15, 2022.
Co-Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results
Co-Diagnostics Gets Approval From India's Central Drugs Standard Control Organization For Manufacturing, Sale of Influenza Multiplex Test
Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR Test
Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Webcast
Southern District Of New York Declines To Dismiss Claims In Putative Class Action Against Medical Test Manufacturer
Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for February 2024
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action CODX
  4. Actualités Co-Diagnostics, Inc.
  5. Autres langues